Literature DB >> 17541209

Reduction of QTc dispersion by the angiotensin II receptor blocker valsartan may be related to its anti-oxidative stress effect in patients with essential hypertension.

Katsuaki Miyajima1, Shinya Minatoguchi, Yoko Ito, Masanori Hukunishi, Yasunari Matsuno, Masao Kakami, Masanori Kawasaki, Kazuhiko Nishigaki, Genzou Takemura, Hisayoshi Fujiwara.   

Abstract

QT dispersion has been reported to increase in patients with essential hypertension, and abnormal QT dispersion is associated with arrythmias and sudden cardiac death. However, whether change in QT dispersion is related to oxidative stress is unclear. We examined the effect of the angiotensin II receptor blocker valsartan on QT dispersion and the relationship between oxidative stress and QT dispersion in patients with essential hypertension. Hypertensive patients whose systolic blood pressure (SBP) was more than 140 mmHg and/or diastolic blood pressure (DBP) was more than 90 mmHg were treated with valsartan. Blood pressure was measured once a month for 6 months. The difference between the maximal and minimal QT intervals within a 12-lead surface ECG was measured and QT dispersion and QTc dispersion corrected by heart rate were obtained before and 6 months after treatment. Left ventricular mass (LVM) assessed by echocardiography was obtained at baseline and 6 months after treatment. Venous blood samples were obtained at baseline and 6 months after treatment to measure serum levels of lipoperoxidation (LPO) and type I and III procollagen. Treatment with valsartan significantly decreased SBP and DBP. QTc dispersion decreased significantly 6 months after treatment with valsartan as compared to the baseline values. Valsartan treatment did not affect the LVM. Valsartan significantly decreased the abnormally high LPO levels. The changes in QTc dispersion were positively correlated with changes in the serum levels of LPO and with changes in DBP. The correlation between changes in LPO and QTc dispersion was more close than that between changes in DBP and QTc dispersion. In conclusion, antihypertensive therapy with valsartan reduces QTc dispersion and this may be related to the ability of valsartan to reduce oxidative stress in patients with essential hypertension.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17541209     DOI: 10.1291/hypres.30.307

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  9 in total

1.  Effect of non-dipper and dipper blood pressure patterns on Tp-Te interval and Tp-Te/QT ratio in patients with metabolic syndrome.

Authors:  Kemal Karaagac; Erhan Tenekecioglu; Osman Can Yontar; Mustafa Kuzeytemiz; Fahriye Vatansever; Ahmet Tutuncu; Ozlem Arican Ozluk; Mustafa Yilmaz; Mehmet Demir
Journal:  Int J Clin Exp Med       Date:  2014-05-15

Review 2.  Molecular studies on coronary artery disease-a review.

Authors:  A Supriya Simon; T Vijayakumar
Journal:  Indian J Clin Biochem       Date:  2013-02-12

3.  Therapeutic role of taurine as antioxidant in reducing hypertension risks in rats.

Authors:  Marwan A Ibrahim; Mostafa M Eraqi; Faiz A Alfaiz
Journal:  Heliyon       Date:  2020-01-17

Review 4.  Pleiotropic Properties of Valsartan: Do They Result from the Antiglycooxidant Activity? Literature Review and In Vitro Study.

Authors:  Kacper Maksymilian Mil; Małgorzata Ewa Gryciuk; Cezary Pawlukianiec; Małgorzata Żendzian-Piotrowska; Jerzy Robert Ładny; Anna Zalewska; Mateusz Maciejczyk
Journal:  Oxid Med Cell Longev       Date:  2021-03-03       Impact factor: 6.543

5.  Effect of vitamins a, C, and e supplementation in the treatment of metabolic syndrome in albino rats.

Authors:  L S Bilbis; S A Muhammad; Y Saidu; Y Adamu
Journal:  Biochem Res Int       Date:  2012-08-16

6.  Effect of antioxidant mineral elements supplementation in the treatment of hypertension in albino rats.

Authors:  S A Muhammad; L S Bilbis; Y Saidu; Y Adamu
Journal:  Oxid Med Cell Longev       Date:  2012-07-17       Impact factor: 6.543

7.  Nigella sativa and Its Protective Role in Oxidative Stress and Hypertension.

Authors:  Xin-Fang Leong; Mohd Rais Mustafa; Kamsiah Jaarin
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-07       Impact factor: 2.629

8.  Evaluation of the Tp-Te interval, Tp-Te/QTc ratio, and QT dispersion in patients with Turner syndrome.

Authors:  Adem Atıcı; Cafer Panç; Ekrem Bilal Karaayvaz; Ahmet Demirkıran; Orkide Kutlu; Kamber Kaşalı; Elmas Kekeç; Lütfullah Sarı; Zeynep Nur Akyol Sarı; Ahmet Kaya Bilge
Journal:  Anatol J Cardiol       Date:  2018-08       Impact factor: 1.596

9.  Oxidative stress and biomarker of TNF-α, MDA and FRAP in hypertension.

Authors:  Manish Kumar Verma; Anoop Jaiswal; Preeti Sharma; Pradeep Kumar; Anand Narayan Singh
Journal:  J Med Life       Date:  2019 Jul-Sep
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.